Lv1
50 积分 2025-01-08 加入
Discovery of AXL Degraders with Improved Potencies in Triple-Negative Breast Cancer (TNBC) Cells
2天前
已完结
Advances and therapeutic opportunities in visual cycle modulation
8天前
已关闭
Tyrosine kinase inhibitors for acute myeloid leukemia: A step toward disease control?
9天前
已完结
Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase Inhibitors
9天前
已完结
Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer Therapy
11天前
已完结
Organization, dynamics and mechanoregulation of integrin-mediated cell–ECM adhesions
12天前
已完结
Piezo1 and its inhibitors: Overview and perspectives
12天前
已完结
Focal adhesion kinase inhibitors in fibrotic diseases therapy: Development and therapeutic potential
13天前
已完结
Discovery of a Pyrimidothiazolodiazepinone as a Potent and Selective Focal Adhesion Kinase (FAK) Inhibitor
13天前
已完结
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment
14天前
已完结
皖公网安备34019202002308
